Re: We're halted....let the speculation begin
|
3
|
Resverlogix Corp.
|
Jul 25, 2017 08:19AM
|
Re: We need help!
|
4
|
Resverlogix Corp.
|
Feb 29, 2016 03:37PM
|
Re: We broke through the Resistance at $2.15
|
4
|
Resverlogix Corp.
|
Oct 05, 2016 02:53PM
|
Re: Warrants conversion!
|
6
|
Resverlogix Corp.
|
Nov 27, 2019 07:37AM
|
Re: Waiting for some great news about Zenith
|
3
|
Zenith Epigenetics
|
Jun 19, 2022 08:19AM
|
Re: VP of clinical operations
|
2
|
Zenith Epigenetics
|
May 21, 2023 06:26PM
|
Re: Vote reminder
|
5
|
Zenith Epigenetics
|
Oct 24, 2023 10:07AM
|
Re: Value
|
4
|
Resverlogix Corp.
|
Jan 20, 2017 09:49PM
|
Re: Value
|
2
|
Zenith Epigenetics
|
Aug 28, 2017 10:43AM
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 01, 2022 03:10PM
|
Re: USA ZHCLF investors
|
3
|
Zenith Epigenetics
|
Oct 29, 2022 08:17AM
|
Re: USA ZHCLF investors
|
2
|
Zenith Epigenetics
|
Nov 02, 2022 12:01PM
|
Re: Update from IR -- Eversana paused?
|
4
|
Resverlogix Corp.
|
Dec 20, 2022 10:36AM
|
Re: Update
|
5
|
Zenith Epigenetics
|
Jul 12, 2017 01:37PM
|
Re: Underwhelmed
|
1
|
Resverlogix Corp.
|
Aug 30, 2017 07:53AM
|
Re: Two articles - Apabetalone for Colon Cancer?
|
6
|
Resverlogix Corp.
|
Jul 09, 2021 10:30AM
|
Re: Tsx 30 news
|
4
|
Resverlogix Corp.
|
Sep 26, 2019 09:53AM
|
Re: Tsx 30 news
|
4
|
Resverlogix Corp.
|
Sep 26, 2019 10:13AM
|
Re: Trillium
|
5
|
Zenith Epigenetics
|
Aug 26, 2021 11:25AM
|
Re: Trillium
|
6
|
Zenith Epigenetics
|
Aug 26, 2021 09:32AM
|